Cannabis is one of 491 small molecule programs targeting Neuropathic Pain. It is currently in Phase 2.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
778 competitors in Osteoarthritis
Cannabis
Voltaren
Bayer Aspirin
Lunesta
Glucophage
Botox
SGLT2 Inhibitor
Lornoxicam
Nigella Sativa Oil
Antidiabetic
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details